When a patient faces a possible cancer diagnosis, medical professionals typically take a biopsy from the suspect tissue for testing in a lab. Those results can determine if cancer is present, and if so, to what extent it has spread, which helps in determining treatment options.
Such testing often uses a reagent—a substance, mixture, or compound used in the testing process. Dako, an Agilent Technologies company, provides reagents to hospitals and medical testing facilities. It also develops antibodies, instruments, and software, all of which are used to enable physicians to better choose a treatment plan and address patient questions.
